Data as of 3:59pm ET
| +0.0006 / +0.11%|
The 1 analysts offering 12-month price forecasts for Acasti Pharma Inc have a median target of 5.59, with a high estimate of 5.59 and a low estimate of 5.59. The median estimate represents a +890.01% increase from the last price of 0.56.
The current consensus among 1 polled investment analysts is to Buy stock in Acasti Pharma Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.